<DOC>
	<DOCNO>NCT01050426</DOCNO>
	<brief_summary>The purpose ass overall survival patient receive either UFT/LV + radiotherapy ( RT ) UFT/LV + Cetuximab + RT neo-adjuvant chemotherapy .</brief_summary>
	<brief_title>A Clinical Study UFT/Leucovorin , Radiotherapy With Without Cetuximab Following Induction Gemcitabine Plus Capecitabine Patients With Locally Advanced Pancreatic Cancer ( PERU )</brief_title>
	<detailed_description>Locally advanced pancreatic cancer carry poor prognosis survival advantage CRT chemotherapy alone . 4 Phase II- III study patient without disease progression 3 month systemic chemotherapy CRT long survival continue chemotherapy . Therefore chemotherapy follow CRT may better approach . Also effect block EGFR evaluate locally advanced pancreatic cancer . Gemcitabine capecitabine combination use neo-adjuvant chemotherapy .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Cetuximab</mesh_term>
	<mesh_term>Leucovorin</mesh_term>
	<criteria>Age &gt; 18 Histological cytological diagnosis adeno undifferentiated nonsmall cell carcinoma pancreas . Considered unresectable base following : extensive peripancreatic lymph node involvement , encasement occlusion SMV SMV/portal vein confluence , direct involvement SMA , coeliac axis , inferior vena cava aorta . Performance status 02 No evidence metastatic disease determine CT scan/ investigation Adequate bone marrow function platelet &gt; 100^9/l ; WBC &gt; 3x10^9/l ; neutrophil &gt; 1.5x10^9/l Serum bilirubin ,1.5 x ULN transaminases &lt; 2.5 x ULN Calculated/measured GFR &gt; 50ml/min No concurrent uncontrolled medical condition No active malignant disease nonmelanotic skin cancer carcinoma situ uterine cervix last 10 year Life expectancy &gt; 3months Adequate contraceptive precaution Informed write consent medical psychiatric condition compromise patient 's ability give inform consent Presence meet . disease Concurrent uncontrolled medical condition Any previous chemo/RT investigational treatment advance pancreatic cancer . Adjuvant chemo + fluoropyrimidine gemcitabine within 12months trial entry Adjuvant RT with/without chemo pancreatic cancer . Pregnancy/breast feeding Patients know malabsorption syndrome ro lack physical treatment upper GI tract . Patients know hypersensitivity 5FU DPD deficiency . Clinically significant CVD</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>